Navigation Links
Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
Date:12/19/2007

health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin currently offers an array of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and Venastat(R) which are sold at the nation's largest food, drug and mass retailers, and has commercialized genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. Interleukin is headquartered in Waltham, MA. For more information about Interleukin and its ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding our growth opportunities and our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations. Because such statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the risk of market acceptance of our products, the risk of technology and product obsolescence, delays in product development, the performance of our commercial partners, the availability of adequate capital, the actions of our competitors and other competitive risks, and those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2006 as amended, filed with the Securities and Exchange Commission, our quarterly reports on Form 10-Q and other filings made by us with the
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
5. Response Genetics Reports Second Quarter 2007 Financial Results
6. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
7. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
8. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
9. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
10. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
11. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2
...search,organization, is pleased to announce that l...r for the Czech Republic, received GCPj,s "Best,Cl...remony was held in,London,s historic Gibson Hall. ...panel of judges who,reviewed his achievements in t...nical trials. The judging panel was composed of a ...
...a,leading, global full-service clinical research o...ident and Chief Financial Officer Karl,"Buzz" Bren...h Annual,Healthcare Conference at the Grand Hyatt ...ity, Sept. 10-11, 2007. Kendle,s presentation is,s...n Time. (Logo: http://www.newscom.com/cgi-bin/pr...
...d of,Pharmacy has approved a 14-module, eight-hour...ewood Pharmacy. The program was developed by the,c...Department. Upon,completion of the program, each t...rate a high level of competence in all state rules... Portability and Accountability Act,(HIPAA) regula...
Other Biology Technology:Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year 2Kendle to Present at Bear Stearns 20th Annual Healthcare Conference 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 2NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program 3
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 33SBio Inc Announces Results of Annual General Meeting 5580 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 1Psychiatric disorders and sexual trauma are associated with lower urinary tract symptoms 59785 2SURF CRUISE CUP 2009 59783 1SURF CRUISE CUP 2009 59783 2
...heres no doubt about it ... the platypus is one od...adaptations like webbed feet to fit its aquatic li...the platypus represents for many a patchwork of ev...g with an international consortium of scientists l... Louis, Mo., has taken this theory to an entirely ...
...onal commerce of ornamental stones has grown all o...ed solid support to the aesthetics of natural ston...on. , Marble is, undoubtedly, the ornamental ston...vilizations have architectural or sculptural works...ir historic heritage. Despite this, nowadays we ha...
...ghts: , Mechanism of action of compound found to... The findings may lead researchers to develop pot...e, amyotrophic lateral sclerosis, Huntingtons dise...nant gliomas , RICHMOND, Va. (May 9, 2008) Virg...overed how an antibiotic works to modulate the act...
Other Biology News:First analysis of platypus genome may impact disease prevention 2Development of new techniques to understand marble quality and durability 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 2Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain 3
...ore tubes to 1 outflow Single-cell and patch deli...everal millisecond) solution change Very small de...on , Solid construction 360, 250 and 100 micro...ny micromanipulator Available in 4, 8, and 16 cha...
steadylite plus Reporter Gene Assay System, 100 mL from PerkinElmer
pTRI-GAPDH-Human (316 bp protected fragment) from Ambion
...nsect Medium is formuatled for the growth of insec... Insect Mediu, Unsupplemented is ideal for transfe...rosylate, and yeastolate, which can interfere with... is formulated for general growth and maintenance ...
Biology Products: